Clinical trials
Growth clinical trials
Below are recruiting growth clinical trials, each written for real people, not researchers. We’re tracking 297 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06207071Recruiting
DHA and ARA supplements for small preterm babies
This trial tests whether giving early supplements of DHA and ARA (nutrients important for brain and eye development) to very small premature infants can improve health outcomes.
Birmingham, AlabamaAges 1 day–3 days - NCT06208397Recruiting
MRI study to understand liver tumor growth patterns
This trial uses MRI scans to study how colorectal cancer that has spread to the liver grows. It may help doctors choose better treatments.
Shenyang, LiaoningAges 18–80 - NCT06212427Recruiting
Preterm infant formula with human milk sugars
This study tests a special supplement added to preterm infant feeding. The supplement contains beneficial sugars found in breast milk, which may help babies digest better and grow. It is for premature babies who have started small feedings but are not yet fully feeding.
LinzAges birth–2 weeks - NCT06226051Recruiting
Growing Little PEAPODS Preterm Baby Study
This study follows the growth and body composition of very premature babies (born between 22 and 32 weeks) to learn how they develop. It uses a special device called the PEAPOD to measure body fat, which may help improve care for preemies.
Madison, WisconsinAges 5 months–7 months - NCT06261346Recruiting
Growth factors in corneal transplant surgery
This study tests whether adding a special growth factor solution to the fluid used during corneal transplant surgery helps the transplant heal better. It is for patients undergoing a specific type of corneal transplant called DSEK or DMEK.
Miami, FloridaAges 18–80 - NCT06278558Recruiting
How mindset affects growth after cancer diagnosis
This study looks at how your thoughts and feelings during early cancer treatment may lead to personal growth. It involves filling out questionnaires about your experience.
ValenciennesAges 18 years+ - NCT06304441Recruiting
Pemetrexed plus lung cancer pill for brain metastasis
This trial tests if adding an injected chemotherapy drug (pemetrexed) to a targeted oral pill (like osimertinib) works better than the pill alone for patients with lung cancer that has spread to the brain and spinal cord lining.
Huizhou, GuangdongAges 18–75 - NCT07357597RecruitingPhase 4
Preventing mouth sores during breast or lung cancer treatment
This trial tests whether a steroid mouthwash can prevent mouth sores caused by the drug Datopotamab Deruxtecan (Dato-DXd). It is for people with certain types of advanced breast cancer or lung cancer who are about to start Dato-DXd for the first time.
Tucson, ArizonaAges 18 years+ - NCT06343051Recruiting
Ultrasound study for newly diagnosed fetal growth restriction
This trial uses a special ultrasound technique to study blood flow in pregnancies where the baby is smaller than expected (fetal growth restriction). It may help doctors better understand how to care for these pregnancies.
New York, New YorkAges 18 years+ - NCT06348134RecruitingPhase 2
Anti-HER2 Therapy Before and After Surgery for HER2-Positive Breast Cancer
This trial tests a targeted therapy (anti-HER2) given before and after surgery for Nigerian women with HER2-positive breast cancer. It aims to see if this treatment helps shrink tumors and improve outcomes.
Ikeja, LagosAges 18 years+ - NCT06395467Recruiting
Integrated treatment for teens with substance use disorder
This trial tests a treatment program for teens and young adults with substance use disorders. It includes family members and is designed to support recovery and personal growth.
Farmington, ConnecticutAges 14–21 - NCT06415487RecruitingPhase 1
Testing a new cell therapy for advanced EGFR-positive solid tumors
This trial tests a new cell therapy called ACE2016 for people with advanced solid tumors that have EGFR on their surface. It may be an option if you have tried at least two other treatments (including a targeted therapy) and your cancer is still growing.
San Diego, CaliforniaAges 18 years+ - NCT06420531Recruiting
Milk and growth in very preterm babies
This study tests whether a special human milk diet helps very preterm babies grow better. It compares two types of human milk fortifiers to see which one leads to healthier growth.
Birmingham, AlabamaAges 6 hours–4 days - NCT06444503Recruiting
A study collecting samples from children with bone problems
This study collects blood and tissue samples from children with bone or growth plate problems to build a research database. It aims to better understand these conditions and may help improve future treatments.
ToulouseAges Up to 99 years - NCT06452199Recruiting
Bifidobacterium infantis for newborns study (BEGIN)
This study gives healthy newborns a probiotic supplement called Bifidobacterium infantis to see if it helps with growth, immune health, and reducing inflammation. It may be a safe way to support your baby's early development.
Herning, Central JutlandAges 1 day–1 week - NCT06452706RecruitingPhase 2
Study of TQB2102 for HER2-negative breast cancer that has spread
This study tests a new drug, TQB2102, for people with HER2-negative breast cancer that has spread and no longer responds to standard treatments. The goal is to see if the drug can shrink tumors or slow the cancer.
Bozhou, AnhuiAges 18–75 - NCT06497959RecruitingPhase 3
Ultrasound study of placenta blood flow
This trial uses a special contrast dye during ultrasound to examine blood flow in the placenta of pregnant women who have chosen to end their pregnancy for medical reasons. It may help understand the role of poor placental blood flow in severe fetal growth restriction.
NancyAges 18–64 - NCT06511648RecruitingPhase 2
Erdafitinib with or without immunotherapy for FGFR-altered bladder cancer
This trial tests a targeted therapy called erdafitinib, either alone or combined with an immunotherapy drug (cetrelimab), for people with muscle-invasive bladder cancer that has a specific FGFR gene change. It may be an option if you cannot take cisplatin chemotherapy and have not had prior treatment for this cancer.
Clermont-FerrandAges 18 years+ - NCT06534307Recruiting
Long-term follow-up for children from PETN studies
This study checks on the health and development of children whose mothers took part in the PETN studies. It involves questionnaires and a physical exam for kids aged 5 and older.
Tübingen, Baden-WurttembergAges 6–18 - NCT06534567Recruiting
Body changes in young triathletes
This study looks at how the bodies of young triathletes change as they grow. It measures things like muscle, fat, and height to see how training affects development.
San Vicent del Raspeig, AlicanteAges 5–17 - NCT06538038Recruiting
Osimertinib plus chemo vs. osimertinib alone for EGFR-mutated NSCLC
This study compares two standard treatments for advanced lung cancer with an EGFR mutation: osimertinib alone versus osimertinib plus chemotherapy. It aims to see which approach works better and is not a trial of a new drug, so you can receive usual care while contributing data.
Birmingham, AlabamaAges 18 years+ - NCT06542809Recruiting
Growth hormone medicine change survey for kids
This survey asks children and teens currently using daily growth hormone shots if they would like to switch to a longer-acting medicine that requires fewer injections. Your answers will help doctors understand patient preferences.
Brussels, Woluwe-saint-lambertAges 1 day–18 years - NCT06550986Recruiting
Polymer device to close false lumen in type B dissection
This trial tests a new polymer device to close the false lumen (an extra channel) in the aorta for people with type B aortic dissection. It may prevent the aorta from growing and reduce the risk of complications.
AucklandAges 18 years+ - NCT06571487Recruiting
Growth hormone resistance in beta cells after pregnancy
This study looks at how the body's insulin-making cells (beta cells) might become resistant to growth hormone after a full-term pregnancy. It compares women who had gestational diabetes to those who didn't, to learn more about diabetes risk. You may join if you had a healthy single-baby pregnancy in the last 5 years and never had type 1 or type 2 diabetes.
Columbia, MissouriAges 18–45
Hear when a new Growth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for growth?
- Yes. Clin2 currently lists 297 recruiting growth studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a growth trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a growth trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.